Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by WORKINMONTANAon Apr 03, 2019 6:05pm
120 Views
Post# 29578982

RE:No Partnership Needed Now!!!

RE:No Partnership Needed Now!!!So in what market space do you compare this to what?

The Chinese, Suadi’s and India shorting the Uranium 232 market or the fact that China tried to take over Aecon $ARE and Trudeau and his Liberal government shut it down?  The general public are oblivious to anything that doesn’t make them money. It’s a crock of $hit just like you and the CBD market. Why the fu XL was $ACB MK so high? Dumm ies? 




Maui527 wrote: Most cannot see the forest for trees today!

Read between the lines, they have the goods, they know it, so why give away the farm?

They can move forward with this funding without a partnership and once they have valued themselves far far beyond what we see today, then they may consider partnersips, when it suits them and to increase the value even higher. 

They have the goods, fast track coming, additional solid results, phase 3, so why give it away for so cheap, when they do not have too...hence the news that we see today! Once they take this up to 1 Billion MC then, they may look for partnership, to take it much higher!

In my opinion this is why we have not seen a partnership to date, not because the have not been able to find one....becasue they DO NOT WANT ONE!!!

Added today, sitting a ltlle over 500k, and I will wait patiently and comfortably, for the best is yet to come!!!

Cheers Longs and let the bashing begin...LOL!!!!


Bullboard Posts